共 31 条
[1]
Harikrishnan R., Balasundaram C., Heo M.S., Diet enriched with mushroom Phellinus linteus extract enhances the growth, innate immune response, and disease resistance of kelp grouper, Epinephelus bruneus against vibriosis, Fish Shellfish Immunol., 30, pp. 128-134, (2011)
[2]
Liu P.C., Lee K.K., Chen S.N., Susceptibility of different isolates of Vibrio harveyi to antibiotics, Microbios, 91, pp. 175-180, (1997)
[3]
Sommerset I., Krossoy B., Biering E., Frost P., Vaccines for fish in aquaculture, Expert Rev. Vaccines, 4, pp. 89-101, (2005)
[4]
Yu L.P., Hu Y.H., Sun B.G., Sun L., Immunological study of the outer membrane proteins of Vibrio harveyi: Insights that link immunoprotectivity to interference with bacterial infection, Fish Shellfish Immunol., 35, pp. 1293-1300, (2013)
[5]
Ningqiu L., Junjie B., Shuqin W., Xiaozhe F., Haihua L., Xing Y., Cunbin S., An outer membrane protein, OmpK, is an effective vaccine candidate for Vibrio harveyi in Orange-spotted grouper (Epinephelus coioides), Fish Shellfish Immunol., 25, pp. 829-833, (2008)
[6]
Zhang C., Yu L., Qian R., Characterization of OmpK, GAPDH and their fusion OmpK-GAPDH derived from Vibrio harveyi outer membrane proteins: Their immunoprotective ability against vibriosis in large yellow croaker (Pseudosciaena crocea), J. Appl. Microbiol., 103, pp. 1587-1599, (2007)
[7]
Zhang C., Yu L., Qian R., Cloning and expression of Vibrio harveyi OmpK* and GAPDH* genes and their potential application as vaccines in large yellow croakers Pseudosciaena crocea, J. Aquat. Anim. Health, 20, pp. 1-11, (2008)
[8]
Sirover M.A., On the functional diversity of glyceraldehyde-3-phosphate dehydrogenase: Biochemical mechanisms and regulatory control, Biochim. Biophys. Acta, 1810, pp. 741-751, (2011)
[9]
Secombes C., Will advances in fish immunology change vaccination strategies?, Fish Shellfish Immunol., 25, pp. 409-416, (2008)
[10]
Garlapati S., Facci M., Polewicz M., Strom S., Babiuk L.A., Mutwiri G., Hancock R.E., Elliott M.R., Gerdts V., Strategies to link innate and adaptive immunity when designing vaccine adjuvants, Vet. Immunol. Immunopathol., 128, pp. 184-191, (2009)